Skip to main content
. 2017 Jun 3;216(2):254–262. doi: 10.1093/infdis/jix265

Figure 2.

Figure 2.

Mean percentages of intracellular Ki67 expression and surface expression of CD38, HLA-DR, and CD57 on CD4+ and CD8+ T cells prior and following completion of chemotherapy in participants with lymphoma or Kaposi sarcoma. Nonsignificant decreases in T-cell activation (CD38+ HLA-DR+ dual positive) and proliferation (Ki67+) were observed by the second postchemotherapy sampling time point. Bars represent mean values and standard error.